Drug
Odm 109
Odm 109: highest development phase Phase 2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-109 NCT02487407 | Phase 2 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Odm 109 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.